alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › phosphorylated-tau181

phosphorylated-tau181

5 studies tagged phosphorylated-tau181, dated 2021-10-14 to 2025-01-16. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum: A systematic review and meta-analysis 2025-01-16
  2. Reference intervals for plasma amyloid-β, total tau, and phosphorylated tau181 in healthy elderly Chinese individuals without cognitive impairment 2023-05-26
  3. Plasma phosphorylated tau181 predicts cognitive and functional decline 2022-12-14

Studies

5 studies carry this tag.

Date range

2021 to 2025

Top journals

  • Alzheimer's & dementia (Amsterdam, Netherlands) 2
  • Alzheimer's research & therapy 1
  • Annals of clinical and translational neurology 1
  • CNS neuroscience & therapeutics 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Blood phosphorylated Tau181 reliably differentiates amyloid-positive from amyloid-negative subjects in the Alzheimer's disease continuum: A systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2025-01-16 Biomarkers

    Regardless of the laboratory technique, blood p-tau181 reliably differentiates A+ and A- subjects.

  2. Reference intervals for plasma amyloid-β, total tau, and phosphorylated tau181 in healthy elderly Chinese individuals without cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's research & therapy 2023-05-26 Biomarkers

    Reference intervals for plasma biomarkers of AD may assist clinicians in making accurate clinical decisions.

  3. Plasma phosphorylated tau181 predicts cognitive and functional decline

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Annals of clinical and translational neurology 2022-12-14 Biomarkers

    Plasma p-tau181 differentiates AD pathology cases from NC with high accuracy.

  4. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. CNS neuroscience & therapeutics 2022-09-08 Biomarkers

    Our findings highlight that plasma p-tau181, alone or combined with NfL, contributes to identifying high-risk AD populations.

  5. Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declines

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2021-10-14 Biomarkers

    Despite assumptions that cognitive changes invariably follow biomarker changes, early neuropsychological difficulties may emerge before/concurrently with plasma p-tau181 changes.

All topic tags with their study counts